Predictors of Initiation of Medication for Opioid Use Disorder and Retention in Treatment Among U.S. Pregnant Women, 2013–2017
Abstract
OBJECTIVE: To describe trends and factors associated with medication administration for opioid use disorder (OUD) and retention in treatment among pregnant women with OUD. METHODS: This is a retrospective, nationwide, cross-sectional analysis of treatment episodes for primary OUD among pregnant women from 2013 to 2017. The primary outcome was initiation of methadone, buprenorphine, or naltrexone. Secondary outcomes were retention in treatment defined as length of treatment episode lasting six months or greater, and completion of treatment. Descriptive statistics and logistic regression were applied to describe trends in, and identify factors associated with the outcomes. RESULTS: There were 42,239 treatment episodes for primary OUD among pregnant women who reported using heroin (65.0%, 27,459), synthetic opioid (33.2%, 14,034), or nonprescribed methadone (1.8%, 746) between 2013 and 2017. Medications for OUD were administered in 47.4% (20,013) of episodes. Retention in treatment occurred in 16.6% of episodes without medications for OUD, and 37.8% of episodes with medications for OUD (P=.01). The rate of medication administration for OUD increased from 41.0% in 2013 to 52.0% in 2017; however, retention rates declined from 39.0% to 33.0% among treatment episodes with medication for OUD. History of at least one prior treatment episode was associated with both administration of medications for OUD and retention in treatment. CONCLUSION: In spite of current guidelines, most treatment episodes for OUD during pregnancy did not involve administration of medications for OUD. Although administration of medications for OUD has improved over time, retention in treatment is lagging. These findings highlight gaps in the U.S. addiction care system.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Retention in opioid use disorder treatment is low and decreases most precipitously during the early postpartum period.
“Even when treatment is initiated, retention in treatment is low, decreasing most precipitously during the early postpartum period [2–6].”
Cites
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., Vandenbroucke, J. P., & Initiative, F. T. S. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-8-200710160-00010 · Cited by 17,796 · see citing works
Comparative effectiveness of different treatment pathways for opioid use disorder.
Wakeman, S. E., Larochelle, M. R., Ameli, O., Chaisson, C. E., McPheeters, J. T., Crown, W. H., Azocar, F., & Sanghavi, D. M. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.20622 · Cited by 995 · see citing works
Neonatal Abstinence Syndrome and Associated Health Care Expenditures: United States, 2000-2009
Patrick, S. W., Schumacher, R. E., Benneyworth, B. D., Krans, E. E., McAllister, J. M., & Davis, M. M. (2012) · JAMA · doi:10.1001/jama.2012.3951 · Cited by 907 · see citing works
Committee Opinion No. 711: Opioid Use and Opioid Use Disorder in Pregnancy
(2017) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000002235 · Cited by 674 · see citing works
Partial observability in bivariate probit models
Poirier, D. J. (1980) · Journal of Econometrics · doi:10.1016/0304-4076(80)90007-x · Cited by 550 · see citing works
Development of a Cascade of Care for responding to the opioid epidemic.
Williams, A. R., Nunes, E. V., Bisaga, A., Levin, F. R., & Olfson, M. (2019) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2018.1546862 · Cited by 332 · see citing works
Incidence of Neonatal Abstinence Syndrome — 28 States, 1999–2013
Ko, J. Y., Patrick, S. W., Tong, V. T., Patel, R., Lind, J. N., & Barfield, W. D. (2016) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6531a2 · Cited by 278 · see citing works
Maternal self-harm deaths: an unrecognized and preventable outcome
Mangla, K., Hoffman, M. C., Trumpff, C., O’Grady, S., & Monk, C. (2019) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2019.02.056 · Cited by 215 · see citing works
Maternal Deaths From Suicide and Overdose in Colorado, 2004–2012
Metz, T. D., Rovner, P., Hoffman, M. C., Allshouse, A. A., Beckwith, K. M., & Binswanger, I. A. (2016) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000001695 · Cited by 204 · see citing works
Daw, J. R., Hatfield, L. A., Swartz, K., & Sommers, B. D. (2017) · Health Affairs · doi:10.1377/hlthaff.2016.1241 · Cited by 187 · see citing works
Prescription Opioids in Pregnancy and Birth Outcomes: A Review of the Literature
Desai, R. J., Brogly, S. B., & Yazdy, M. M. (2015) · Journal of Pediatric Genetics · doi:10.1055/s-0035-1556740 · Cited by 182 · see citing works
Schiff, D. M., Nielsen, T. C., Hoeppner, B. B., Terplan, M., Hansen, H., Bernson, D., Diop, H., Bharel, M., Krans, E. E., Selk, S., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.5734 · Cited by 179 · see citing works
Developing an opioid use disorder treatment cascade: A review of quality measures
Williams, A. R., Nunes, E. V., Bisaga, A. M., Pincus, H. A., Johnson, K., Campbell, A. N. C., Remien, R. H., Crystal, S., Friedmann, P. D., LEVIN, F. R., et al. (2018) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2018.06.001 · Cited by 172 · see citing works
Brogly, S. B., Saia, K., Walley, A. Y., Du, H. M., & Paola Sebastiani, B. (2014) · American Journal of Epidemiology · doi:10.1093/aje/kwu190 · Cited by 168 · see citing works
Recent trends in treatment admissions for prescription opioid abuse during pregnancy
Martin, C. E., Longinaker, N., & Terplan, M. (2014) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2014.07.007 · Cited by 166 · see citing works
Maternal drug-related death and suicide are leading causes of postpartum death in California
Goldman-Mellor, S. J., & Margerison, C. E. (2019) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2019.05.045 · Cited by 156 · see citing works
Association of Pregnancy and Insurance Status With Treatment Access for Opioid Use Disorder
Patrick, S. W., Richards, M. R., Dupont, W. D., McNeer, E. A., Buntin, M. B., Martin, P., Davis, M. M., Davis, C. S., Hartmann, K. E., Leech, A. A., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.13456 · Cited by 137 · see citing works
Barriers to Accessing Treatment for Pregnant Women with Opioid Use Disorder in Appalachian States
Patrick, S. W., Buntin, M. B., Martin, P., Scott, T. A., Dupont, W. D., Richards, M. R., & Cooper, W. O. (2018) · Substance Abuse · doi:10.1080/08897077.2018.1488336 · Cited by 105 · see citing works
Terplan, M., Ramanadhan, S., Locke, A., Longinaker, N., & Lui, S. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006037.pub3 · Cited by 101 · see citing works
Medication-Assisted Treatment Use Among Pregnant Women With Opioid Use Disorder
Krans, E. E., Kim, J. Y., James, A. E., Kelley, D., & Jarlenski, M. (2019) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000003231 · Cited by 101 · see citing works
Hand, D. J., Short, V. L., & Abatemarco, D. J. (2017) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2017.01.011 · Cited by 71 · see citing works
Sufrin, C., Sutherland, L. C., Beal, L., Terplan, M., Latkin, C. A., & Clarke, J. G. (2020) · Addiction · doi:10.1111/add.15030 · Cited by 70 · see citing works
Evaluation of State-Mandated Reporting of Neonatal Abstinence Syndrome — Six States, 2013–2017
Jilani, S. M., Frey, M. T., Pepin, D. A., Jewell, T., Jordán, M., Miller, A. M., Robinson, M., Mars, T. S., Bryan, M., Ko, J. Y., et al. (2019) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6801a2 · Cited by 64 · see citing works
Lo‐Ciganic, W., Donohue, J. M., Kim, J. Y., Krans, E. E., Jones, B. L., Kelley, D., James, A. E., & Jarlenski, M. (2018) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4647 · Cited by 56 · see citing works
Predictors of treatment retention in postpartum women prescribed buprenorphine during pregnancy
O’Connor, A. B., Uhler, B., O’Brien, L. M., & Knuppel, K. (2017) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2017.12.001 · Cited by 39 · see citing works
To Battle The Opioid Overdose Epidemic, Deploy The ‘Cascade Of Care’ Model
Williams, A. R., Nunes, E. V., & Olfson, M. (2017) · doi:10.7916/d8rx9qf3 · Cited by 37 · see citing works
Chronic Opioid Use During Pregnancy
Stanhope, T. J., Gill, L. A., & Rose, C. H. (2013) · Clinics in Perinatology · doi:10.1016/j.clp.2013.05.015 · Cited by 32 · see citing works
One-Year Postpartum Mental Health Outcomes of Mothers of Infants with Neonatal Abstinence Syndrome
Corr, T. E., Schaefer, É., Hollenbeak, C. S., & LESLIE, D. L. (2020) · Maternal and Child Health Journal · doi:10.1007/s10995-019-02839-9 · Cited by 29 · see citing works
Probation clients’ barriers to access and use of opioid use disorder medications
Reichert, J., & Gleicher, L. (2019) · Health & Justice · doi:10.1186/s40352-019-0089-6 · Cited by 26 · see citing works
Maternity Care for Pregnant Women with Opioid Use Disorder: A Review
Rizk, A. H., Simonsen, S. E., Roberts, L. A., Taylor-Swanson, L. J., Lemoine, J., & Smid, M. C. (2019) · Journal of Midwifery & Women s Health · doi:10.1111/jmwh.13019 · Cited by 23 · see citing works
Jancaitis, B., Kelpin, S. S., Masho, S., May, J. C., Haug, N., & Svikis, D. (2019) · Women & health · doi:10.1080/03630242.2019.1610829 · Cited by 19 · see citing works
To Battle The Opioid Overdose Epidemic, Deploy The ‘Cascade of Care’ Model
(2017) · Forefront Group · doi:10.1377/forefront.20170313.059163 · Cited by 18 · see citing works
Treatment Episode Data Set -- Discharges (TEDS-D), 2008
United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies (2011) · ICPSR Data Holdings · doi:10.3886/icpsr29901 · Cited by 12 · see citing works
Treatment Episode Data Set -- Discharges (TEDS-D), 2008
United States Department Of Health And Human Services. Substance Abuse And Mental Health Services Administration. Office Of Applied Studies (2011) · ICPSR Data Holdings · doi:10.3886/icpsr29901.v1 · Cited by 9 · see citing works
Obstetrician-Gynecologists' referral practices for substance use during pregnancy
Coleman‐Cowger, V. H., Snead, C. M., & Schulkin, J. A. (2018) · Clinical Obstetrics Gynecology and Reproductive Medicine · doi:10.15761/cogrm.1000223 · Cited by 6 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Commentary Article: Opioid use Disorder Cascade of Care Framework Design: A Roadmap
Williams, A. R., Johnson, K., Parks, C. L., Reif, S., Socias, M. E., Henry, B. F., Neighbors, C. J., Gordon, A. J., Horgan, C. M., Nosyk, B., et al. (2022) · Substance Abuse · doi:10.1080/08897077.2022.2074604 · Cited by 33 · see citing works
Xu, K. Y., Schiff, D. M., Jones, H. E., Martin, C. E., Kelly, J. C., Bierut, L. J., Carter, E. B., & Grucza, R. A. (2023) · Journal of General Internal Medicine · doi:10.1007/s11606-023-08306-0 · Cited by 24 · see citing works
Austin, A. E., Durrance, C. P., Ahrens, K. A., Chen, Q., Hammerslag, L. R., McDuffie, M. J., Talbert, J., Lanier, P., Donohue, J. M., & Jarlenski, M. (2023) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2023.109868 · Cited by 22 · see citing works
Categorization of Opioid Use Among Pregnant People and Association With Overdose or Death
Camden, A., To, T. M., Ray, J. G., Gomes, T., Bai, L., & Guttmann, A. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.14688 · Cited by 12 · see citing works
Home Induction of Buprenorphine for Treatment of Opioid Use Disorder in Pregnancy
Kelly, J. C., Raghuraman, N., Stout, M. J., Russell, S., Perez, M. J., Nazeer, S. A., Helou, N. E., Zhang, F., & Carter, E. B. (2021) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000004539 · Cited by 10 · see citing works
Medication for Opioid Use Disorder and Treatment Retention Among Pregnant Individuals
Ganetsky, V. S., Krawczyk, N., & Kennedy‐Hendricks, A. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.6069 · Cited by 9 · see citing works
Wang, X., Meisel, Z. F., Kellom, K. S., Whitaker, J., Strane, D., Chatterjee, A., Rosenquist, R., & Matone, M. (2023) · Drug and Alcohol Dependence Reports · doi:10.1016/j.dadr.2023.100206 · Cited by 8 · see citing works
Self-citationTiako, M. J. N., Meinhofer, A., Friedman, A. B., South, E. C., Epstein, R. L., Meisel, Z. F., & Morgan, J. R. (2022) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2022.05.041 · Cited by 8 · see citing works
Self-citationKitsantas, P., Aljoudi, S. M., Baker, K. M., Peppard, L., & Oh, K. M. (2022) · Journal of Substance Use and Addiction Treatment · doi:10.1016/j.josat.2023.208960 · Cited by 8 · see citing works
Goldman-Mellor, S. J., Jensen, J., Cruz, S. S., Olfson, M., Gemmill, A., Yan, Y., & Margerison, C. E. (2024) · American Journal of Epidemiology · doi:10.1093/aje/kwae177 · Cited by 7 · see citing works
Ganetsky, V. S., Heil, J., Yates, B., Jones, I., Hunter, K., Rivera, B., Wilson, L., Salzman, M., & Baston, K. (2021) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000912 · Cited by 7 · see citing works
Gerdts, G., Sale, K., Raynor, P., Schiff, D. M., Terplan, M., Bush, E., & Nidey, N. (2025) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000001465 · Cited by 4 · see citing works
Marks, S. J., Pham, H., McCray, N., Palazzolo, J. R., Harrell, A., Lowe, J., Bachireddy, C., Guerra, L., Cunningham, P. J., & Barnes, A. J. (2023) · Substance Abuse · doi:10.1177/08897077231186218 · Cited by 3 · see citing works
Monitoring Opioid-Use-Disorder Treatment Adherence Using Smartwatch Gesture Recognition
Smith, A., Jerzmanowski, K., Raynor, P., Corbett, C. F., & Valafar, H. (2025) · Sensors · doi:10.3390/s25082443 · Cited by 2 · see citing works
Martins, S., Huang, Y., Fan, W., Segura, L. E., Bruzelius, E., Marziali, M. E., Khan, A., & Philbin, M. M. (2026) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2026.113158 · Cited by 2 · see citing works
Lord, S. E., & Rao, D. (2025) · Annals of Medicine · doi:10.1080/07853890.2025.2486585 · Cited by 1 · see citing works
King, C., Laynor, G., McNeely, J., Fawole, A., Lee, M., Terplan, M., & Choi, S. (2024) · PLoS ONE · doi:10.1371/journal.pone.0300183 · Cited by 1 · see citing works
Kelly, J. C., Ayala, N. K., Holroyd, L. E., Raghuraman, N., Carter, E. B., Williams, S. A. S., Mills, M., Friedman, H., Zhang, F., & Townsel, C. (2023) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2023.100998 · Cited by 1 · see citing works
Oh, K. M., Eklou, K. P., Beran, K., Elnahas, N. H., Bates, R. A., & Kitsantas, P. (2025) · Journal of the American Association of Nurse Practitioners · doi:10.1097/jxx.0000000000001123
Owusu, D. N., Aderibigbe, I., Adediji, P. O., Trull, L. H., Ahuja, M., & Mamudu, H. M. (2026) · Journal of Drug Issues · doi:10.1177/00220426261488722
- Authors
- Nguemeni Tiako, M. J., Friedman, A., Culhane, J., South, E., & Meisel, Z. F.
- Affiliations
- Yale University (US)
- Venue
- Obstetrics & Gynecology
- Published
- 2021-03-10
- Volume
- 137
- Issue
- 4
- Pages
- 687-694
- ISSN
- 0029-7844 (ISSN-L)
- OpenAlex
- W3135294211
- Cited by
- 21
- References
- 34
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 2 · 2023: 6 · 2022: 4 · 2021: 2
- FWCI
- 3.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Obstetrics and Gynecology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- opioid use disorder, pregnancy, maternal opioid use, methadone, buprenorphine, naltrexone, treatment retention, treatment completion, heroin use, synthetic opioids
- MeSH terms
- Adolescent, Adult, Cross-Sectional Studies, Female, Humans, Middle Aged, Narcotic Antagonists, Opioid-Related Disorders, Patient Compliance, Pregnancy, Pregnancy Complications, Prenatal Care, Retrospective Studies, United States, Young Adult, Opiate Substitution Treatment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
